14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 APRE stock ended at $5.17. This is 1.71% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 3.48% from a day low at $5.17 to a day high of $5.35.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Aprea Therapeutics Inc. prices

Date Open High Low Close Volume
May 07, 2024 $5.35 $5.35 $5.17 $5.17 5 137
May 06, 2024 $5.25 $5.35 $5.25 $5.26 3 460
May 03, 2024 $5.40 $5.44 $5.35 $5.35 1 961
May 02, 2024 $5.41 $5.45 $5.33 $5.45 2 189
May 01, 2024 $5.10 $5.25 $5.10 $5.25 2 360
Apr 30, 2024 $5.16 $5.17 $4.90 $5.10 14 862
Apr 29, 2024 $5.01 $5.26 $5.01 $5.08 2 550
Apr 26, 2024 $5.20 $5.20 $5.05 $5.20 4 734
Apr 25, 2024 $5.02 $5.47 $5.02 $5.35 9 065
Apr 24, 2024 $5.37 $5.37 $5.06 $5.17 6 204
Apr 23, 2024 $5.14 $5.62 $5.14 $5.37 2 596
Apr 22, 2024 $5.75 $5.75 $5.12 $5.12 11 802
Apr 19, 2024 $5.59 $5.79 $5.31 $5.35 7 192
Apr 18, 2024 $5.61 $5.61 $5.61 $5.61 862
Apr 17, 2024 $5.71 $5.85 $5.71 $5.73 2 277
Apr 16, 2024 $5.73 $5.98 $5.68 $5.85 5 086
Apr 15, 2024 $6.00 $6.01 $5.71 $5.90 8 430
Apr 12, 2024 $6.23 $6.23 $5.69 $5.71 4 379
Apr 11, 2024 $5.87 $6.05 $5.85 $5.90 3 321
Apr 10, 2024 $5.91 $6.20 $5.32 $6.20 6 139
Apr 09, 2024 $5.90 $6.17 $5.90 $6.04 6 525
Apr 08, 2024 $6.17 $6.40 $5.82 $6.20 11 639
Apr 05, 2024 $6.27 $6.48 $6.00 $6.30 9 788
Apr 04, 2024 $6.10 $6.48 $6.01 $6.17 16 915
Apr 03, 2024 $6.67 $6.70 $6.30 $6.67 10 186
Click to get the best stock tips daily for free!

About Aprea Therapeutics Inc.

Aprea Therapeutics. Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATR... APRE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT